|
Canada-0-TileCeramicDistributors Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- Paul Cousins, CPA - Senior Accountant I Analyst | LinkedIn
Senior Accountant I Analyst · Experience: Eupraxia Pharmaceuticals Inc · Education: Sauder School of Business · Location: Vancouver · 195 connections on LinkedIn View Paul Cousins,
- Eupraxia Pharmaceuticals: Employee Directory | ZoomInfo. com
Search our free database to find email addresses and direct dials for Eupraxia Pharmaceuticals employees
- Eupraxia Pharmaceuticals Inc. - ContactOut
Who are the decision makers in Eupraxia Pharmaceuticals Inc ? The decision makers in Eupraxia Pharmaceuticals Inc are Andrew Dye, Ash Bassett, Bruce Cousins, etc Click to Find Eupraxia Pharmaceuticals Inc decision makers emails
- Eupraxia Pharmaceuticals Org Chart + Executive Team
See the executive team of Eupraxia Pharmaceuticals and its org chart, featuring 20 leaders like James Helliwell, Alex Rothwell and Paul Brennan
- Home - Eupraxiapharma
Eupraxia is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug in the right place for the right amount of time
- Eupraxia Pharmaceuticals Inc. Management Team | Org Chart
The Eupraxia Pharmaceuticals Inc management team includes Troy Loss (Vice President CMC), Katie Groulx (Legal, Outsourcing and Vendor Management), and Sylvain Lanouette (Director of Medical Affairs)
- Eupraxia Pharmaceuticals Inc. (EPRX) Leadership Management Team . . .
Learn about Eupraxia Pharmaceuticals Inc (EPRX) stock's management team Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team
- EPRX | Eupraxia Pharmaceuticals Inc. Company Profile Executives - WSJ
Company profile for Eupraxia Pharmaceuticals Inc including key executives, insider trading, ownership, revenue and average growth rates View detailed EPRX description address
- Eupraxia Pharmaceuticals Inc. : Governance, Directors and Executives . . .
Eupraxia Pharmaceuticals Inc is a Canada-based clinical-stage biotechnology company The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs
- March 31: Hezbollah hits north with rocket barrage, lightly hurting 3 . . .
On LinkedIn, Tofigh Daru says it develops and produces active pharmaceutical ingredients “in the anticancer, narcotics, cardiovascular to immunomodulatory segments ”
|
|